Cite
MLA Citation
Hertzel C. Gerstein et al.. “Design and baseline characteristics of the AMPLITUDE‐O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon‐like peptide‐1 receptor agonist.” Diabetes, obesity & metabolism, vol. 23, no. 2, 2021, pp. 318–323. http://access.bl.uk/ark:/81055/vdc_100118930309.0x000025